Get access to our best features
Get Started
Subscribe
Israel-Hamas Conflict
Michael Cohen
Donald Trump
US Economy
US Politics
Joe Biden
US Crime
Republican Party
Golf
Senate
Baseball
Tariffs
US Social Issues
Get access to our best features
Get Started
Published 2 months ago

Billion dollar deal: Novo Nordisk buys German biotech company

Summary by Salzburger Nachrichten
The Danish pharmaceutical company Novo Nordisk is acquiring the biotech company Cardior Pharmaceuticals from Hanover for more than one billion euros.

0 Articles

All
Left
Center
Right
rnd.dernd.de

For a billion euros: That’s why Novo Nordisk buys German biotech company Cardior

Worldwide, 65 million people suffer from heart failure. A promising drug against the disease has been developed by the Hanoverian company Cardior, which the Danish group Novo Nordisk takes over mainly for this reason. The Hanover Medical University also benefits from the high purchase price.

2 months ago·Germany
Read Full Article
focus.defocus.de

Novo Nordisk pays over a billion for German biotech company

Novo Nordisk acquires biotech company Cardior Pharmaceuticals from Hanover. In doing so, the Danish pharmaceutical company wants to strengthen its presence in the area of cardiovascular diseases.

2 months ago·Berlin, Germany
Read Full Article
stern.destern.de

Novo Nordisk acquires biotech company Cardior

Novo Nordisk, known for diabetes medications and weight loss injections, secures expertise in heart drugs with the acquisition of start-up Cardior. The Danish pharmaceutical company Novo Nordisk is acquiring the biotech company Cardior Pharmaceuticals from Hannover for more than one billion euros.

2 months ago·Germany
Read Full Article
HeiseHeise

Novo Nordisk pharmaceutical company buys Biotech company Cardior

So far, Novo Nordisk is known for diabetes drugs and its slimming syringe. With the takeover, the Danes are securing expertise in heart preparations.

2 months ago·Germany
Read Full Article
LVZ - Leipziger VolkszeitungLVZ - Leipziger Volkszeitung

For a billion euros: That’s why Novo Nordisk buys German biotech company Cardior

Worldwide, 65 million people suffer from heart failure. A promising drug against the disease has been developed by the Hanoverian company Cardior, which the Danish group Novo Nordisk takes over mainly for this reason. The Hanover Medical University also benefits from the high purchase price.

2 months ago·Leipzig, Germany
Read Full Article
borsen.dkborsen.dk

Novo Nordisk acquires biotech company for up to 7.6 billion DKK.

Novo Nordisk acquires the German biotech company Cardior Pharmaceuticals for up to 1,025 million euros, or...

2 months ago
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

BiotechBiotech
GermanyGermany
Trending Topics
Ground News logo
US
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc.
News
For You
Search
BlindspotLocal